BlackRock Capital Allocation Term Trust (NYSE:BCAT) Sets New 1-Year Low – What’s Next?

BlackRock Capital Allocation Term Trust (NYSE:BCAT)’s stock price reached a new 52-week low on Friday. The company traded as low as $12.88 and last traded at $12.93, with a volume of 100,648 shares. The stock had previously closed at $13.20.

BlackRock Capital Allocation Term Trust Trading Down 2.0%

The company’s fifty day moving average is $13.92 and its 200-day moving average is $14.97.

BlackRock Capital Allocation Term Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Tuesday, December 22nd. Shareholders of record on Friday, December 11th will be issued a $0.2501 dividend. This represents a $3.00 annualized dividend and a yield of 23.2%. The ex-dividend date of this dividend is Friday, December 11th.

Institutional Investors Weigh In On BlackRock Capital Allocation Term Trust

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Advisors Asset Management Inc. acquired a new position in BlackRock Capital Allocation Term Trust in the third quarter valued at approximately $3,260,000. TD Capital Management LLC grew its stake in shares of BlackRock Capital Allocation Term Trust by 5.2% during the 3rd quarter. TD Capital Management LLC now owns 39,415 shares of the company’s stock worth $540,000 after purchasing an additional 1,948 shares during the period. Commonwealth Equity Services LLC grew its stake in shares of BlackRock Capital Allocation Term Trust by 11.6% during the 3rd quarter. Commonwealth Equity Services LLC now owns 90,264 shares of the company’s stock worth $1,237,000 after purchasing an additional 9,385 shares during the period. Capital CS Group LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust during the 3rd quarter valued at approximately $148,000. Finally, Oppenheimer & Co. Inc. increased its holdings in shares of BlackRock Capital Allocation Term Trust by 81.8% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 35,554 shares of the company’s stock valued at $487,000 after purchasing an additional 16,000 shares in the last quarter. 36.12% of the stock is owned by institutional investors and hedge funds.

BlackRock Capital Allocation Term Trust Company Profile

BlackRock Capital Allocation Term Trust (BCAT) is a diversified, publicly traded closed-end investment fund managed by BlackRock Advisors. It seeks to provide total return through a combination of income and capital appreciation. The fund invests across global markets in equity and debt securities, and may also use derivatives and other investment strategies. Its portfolio can include securities with varying credit quality and risk profiles. BCAT began operations in 2020 and is structured as a term trust, with a planned termination date subject to the fund’s governing documents and any required shareholder action.